Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Clinical trial NCT01967537 · COMPLETED

Trial details

NCT number: NCT01967537
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Von Hippel-Lindau Syndrome Hippel-Lindau Disease

Start date: 2013-10-18
Primary completion: 2017-12-17
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.